Actionable trade ideas with defined risk and time horizons.
Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.
2,827 total articles
Information Services Group (III) is a small-cap consulting and sourcing advisor with roughly $272M market cap, positive free cash flow and an attractive dividend. Continued enterprise demand for AI vendor assessments, sourcing and transformation work creates a near-term catalyst. This trade targets a re-test of the 52-week high as multiple and sent…
Chevron's recent price breakout is supported by accelerating production, wide free cash flow, a clean balance sheet, and a reliable dividend. We lay out an actionable trade: entry on confirmed breakout, a defined stop, and a near-term target that captures upside while respecting commodity volatility.
Celestica's exposure to AI infrastructure (servers, storage, networking) and the newly launched SD6300 give the stock a clear demand story even as management increases CAPEX to capture larger contracts. The trade: buy on a pullback to $285.11, stop at $260.00, target $340.00 over a mid-term 45 trading day horizon — positive catalyst-driven trade wi…
Sangoma is a small-cap Communications-as-a-Service provider trading at $4.99 with a market cap of roughly $158M and a sub-1.0 P/B. Recent operating dynamics point to a likely margin inflection from higher-margin trunking and platform revenue that the market is not fully pricing. This idea is a tactical long for a mid-term horizon (45 trading days) …
Oracle's plan to raise $45-50 billion to fund AI-focused cloud expansion has pushed the stock lower but also creates a high-conviction trade: buy into the sell-off at $160 with a long-term horizon. Technicals show oversold conditions, fundamentals show a profitable software base and strong ROE, and analysts still forecast upside. The trade accepts …
Exxon Mobil is trading near $138 while delivering industry-leading production and cash flow. With a market cap around $580B, EV/EBITDA near 9.2 and roughly $24B in free cash flow, the company offers a mix of yield, buybacks and operational optionality that buffers it against cyclical oil weakness. This trade idea lays out entry, stops and targets f…
Apple's newest window of upside is less about heavy new factories and more about software-led AI features that accelerate iPhone replacement and lift services monetization. The company prints massive free cash flow and runs a disciplined capital plan; combine that with early signs of a 23% iPhone sales surge and constructive technicals and you have…
Arbutus is a small-cap clinical-stage biotech where two near-term vectors - LNP-related litigation and follow-up imdusiran efficacy readouts - can produce outsized moves. Market capitalization sits near $844M while recent clinical data showed meaningful reductions in HBsAg. High short interest and above-average volume amplify both upside and downsi…
Salesforce is trading near multi-month lows despite healthy margins, strong free cash flow, and a clear path to AI-led product monetization. Use a defined-entry trade to capture a rebound as Agentforce 360 and broader generative AI adoption begin to show through in revenue and ARR acceleration.
Village Farms (VFF) has been quietly shifting its earnings mix from produce toward higher-margin cannabis exports and energy operations. With a market cap near $377M, positive free cash flow last year, and an EU-GMP export win announced 01/26/2026, the risk/reward favors a tactical long over the next 45 trading days. Entry $3.27, target $4.20, stop…
TransMedics' organ care platform is set to benefit from an expanding international footprint after reports of an Italian NOP program. With a $4.58B market cap, positive free cash flow ($120.6M last reported), and heavy short interest that could amplify moves, this is a tactical long for patient traders who accept valuation risk. Entry $134.03, stop…
Credo Technology (CRDO) has been punished since its December peak despite accelerating revenue and improving margins. The combination of strong free cash flow, an attractive enterprise-value backdrop and an oversold technical picture argues for a tactical long. This trade idea lays out an entry at $122.00, a stop at $110.00, and a $170.00 target ov…
HP Inc. (HPQ) trades at $19.80 with a 5.9% yield, a single-digit P/E, and meaningful free cash flow. The company is buying back shares aggressively and returning cash via dividends while product refreshes for AI-capable PCs create an operational catalyst. This trade targets a rebound toward $24 over the next 45 trading days with a conservative stop…
JinkoSolar (JKS) trades at a sub-1x PB multiple and yields nearly 5%, but the company still operates in a brutally cyclical industry. This trade idea is a mid-term swing long: enter at the market ($26.56), target $31.50 and stop at $23.00. The trade captures re-rating potential if module prices stabilize and Chinese policy turns neutral-to-positive…
Flagship Communities (MHCUF) is a small-cap, OTC-listed manufactured-housing REIT that trades near $19.92 and offers a reliable monthly cash distribution track record. Technicals show a calm base and an RSI near 55, while short interest and bursts of short volume highlight low float and episodic liquidity. This trade targets long-term income plus a…
Customers Bancorp (CUBI) is a mid-sized regional bank trading at a modest P/B and an attractive free cash flow yield. The company carries regulatory and legal overhang from AML and risk-management deficiencies, but the balance sheet, recent operating momentum, and valuation create an asymmetric trade: limited downside to a defined stop and meaningf…
Byrna (BYRN) has pulled back roughly 25% from recent short-term levels into a low $13s support zone, leaving an oversold setup (RSI ~27) and attractive risk/reward for a tactical long. The company sits on a $313M market cap, positive trailing EPS (~$0.70), and operates in a less-lethal market expected to grow over the next five years. This is a hig…
Lamb Weston (LW) has been punished by fast-food demand softness and a messy ERP rollout, but improving cash flow, reasonable valuation, and early signs of operational stabilization argue for a mid-term long trade. Entry at the current price, a clear stop at $39.50 and a target near $55 offer a favorable risk-reward if order fulfillment and margin s…
Berkshire Hathaway is a diversified cash-generative conglomerate trading at a reasonable multiple with a fortress balance sheet and active capital allocation under CEO Greg Abel. This trade idea lays out a clear long entry at the current price, a conservative stop and an upside target based on tangible valuation and catalyst paths over a 180 tradin…
Halozyme is trading near $76 after raising 2026 guidance, securing Surf Bio and projecting royalty revenue north of $1 billion. The setup supports a long trade toward $95 over the next 180 trading days, while acknowledging execution and clinical risks. Entry $76.21, stop $64.00, target $95.00.
Deckers reported a blowout 3Q and raised fiscal 2026 guidance, driven by HOKA strength and resilient UGG demand. Fundamentals and cash flow back a buy here; technicals show momentum and short-interest is modest. Trade plan: enter $118.00, stop $108.00, target $150.00 over a long-term (180 trading days) horizon.
Hitachi is a diversified industrial with a growing Digital Systems & Services segment that looks increasingly SaaS-like. With a $162.2B market cap, improving technicals and supportive macro drivers for Japanese equities, we reiterate a buy and propose a position trade sized to risk a 2.4% stop under today's level. The thesis is tactical: own exposu…
Oshkosh (OSK) appears undervalued relative to its cash generation and defense exposure. With an enterprise value near $10.1B, free cash flow of $754.8M and a P/E in the mid-teens, the risk/reward favors a long position. We outline an actionable trade with entry, stop and target while flagging the operational and macro risks that could derail the se…
JBS N.V. offers an attractive risk-reward into 2026: cash-flowing protein assets, recent liability rationalization and consistent global demand point to upside from $15.72, but commodity cycles, FX and event risk argue for a disciplined entry and tight stop. This trade idea lays out an actionable long with entry, stop and target and explains the fu…
AppLovin's AI-inflected growth story still looks impressive on top-line metrics, but steep multiples, bearish technical momentum, and crowded positioning set up a mid-term short. We lay out an entry at $484.10, a stop at $525.00, and a target of $350.00 over ~45 trading days, with clear catalysts and risk management.
